The effect of magnesium and zinc co-supplementation in patients with coronary heart disease and type 2 diabetes mellitus

Phase 3

• Conditions: coronary heart disease and type 2 diabetes mellitus.; Chronic ischemic heart disease, unspecified; I25.9

• Registration Number: IRCT20130211012438N31
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients with coronary disease on angiography ;patients with diabetes with American Diabetes Association; age 40 to 95 years;No smoking

Exclusion Criteria

thyroid disease;No change in levels of LDL patients six weeks after the intervention;Infection; Consumption of any type of supplement (vitamin, mineral, etc.) by the patient in the last 3 months; Acute myocardial infarction in the last 3 months; Cardiac surgery in the last 3 months; Significant kidney failure; Significant liver failure; Unwillingness to cooperate; Antibiotic use during study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HOMA-Index. Timepoint: Baseline and End-of-trial. Method of measurement: Formula calculation.